At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
[E S] A Greek, Post-marketing, Observational Study of the quAlity of Life in Patients With Psoriasis Treated With Adalimumab - GOAL Study
In Brief
An observational study for Psoriasis. Completed, enrolled 500 participants across 61 sites.
Detailed Summary
Primary objective * To evaluate the quality of life of Adalimumab treated patients over a period of 12 months Secondary objectives * To evaluate the long-term efficacy of Adalimumab in patients with moderate to severe chronic plaque psoriasis as prescribed by the dermatologists in day-to-day clinical practice and in accordance with the terms of the European marketing authorization. * To evaluate changes in patients quality of life according to treatment response over a 12-month period * To observe and assess the long term use and safety of Adalimumab as prescribed by the dermatologist in a normal clinical setting and in accordance with the terms of the European marketing authorization.